Identification of the Critical Residues Involved in Peptidoglycan Detection by Nod1*
- Stephen E. Girardin‡§,1,2,
- Muguette Jéhanno¶,1,
- Dominique Mengin-Lecreulx∥,
- Philippe J. Sansonetti‡,
- Pedro M. Alzari** and
- Dana J. Philpott¶,1
- ‡Unité de Pathogénie Microbienne Moléculaire, INSERM U389, §Groupe Inserm Avenir “Peptidoglycan and Innate Immunity,” ¶Groupe Immunité Innée et Signalisation, **Unité de Biochimie Structurale, Institut Pasteur, 28 Rue du Dr. Roux, 75724 Paris Cedex 15, France and the ∥Enveloppes Bactériennes et Antibiotiques, IBBMC, UMR 8619 CNRS, Université Paris-Sud, Bât. 430, 91405 Orsay, France
- ↵2 To whom correspondence should be addressed: Institut Pasteur, 28 Rue du Dr. Roux, 75724 Paris, France. Tel.: 33-1-40-61-37-71; Fax: 33-1-45-68-89-53; E-mail: girardin{at}pasteur.fr.
Abstract
Nod1 is an intracellular pattern recognition molecule activated following bacterial infection, which senses a specific muropeptide (l-Ala-d-Glu-meso-DAP (diaminopimelic acid); “TriDAP”) from peptidoglycan. Here we investigated the molecular basis of TriDAP sensing by human (h) Nod1. Our results identified the domain responsible for TriDAP detection in the center of the concave surface of hNod1 leucine-rich repeat domain. Amino acid residues critical for sensing define a contiguous surface patch that is largely conserved in Nod1 proteins from different species. Accordingly, the distinct specificities of human versus murine Nod1 toward muropeptide detection were also found to lie in this central cleft. Several splicing variants of Nod1 lacking repeats 7-9 have been characterized recently, the relative balance of which is thought to correlate with the onset of asthma or inflammatory bowel disease. We demonstrated that these isoforms failed to transduce NF-κB activation upon muropeptide stimulation. This study provided insights into the molecular mechanisms responsible for the detection of bacterial peptidoglycan by Nod1 and suggested that defects in Nod1-dependent peptidoglycan sensing may contribute to elicit certain inflammatory disorders.
- Received August 30, 2005.
- Revision received September 16, 2005.
- The American Society for Biochemistry and Molecular Biology, Inc.











